Outcome of Infants Born to Women with Chronic Hepatitis B: A Local Risk-Based Strategy in a Low Prevalence Country
Maternal and Child Health Journal · 2024
DOI: 10.1007/s10995-024-03909-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Maternal and Child Health Journal, 2024. Verfasst von Giannina Izquierdo Copiz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, Universidad de Chile, Santiago, Chile. gizquierdo@uchile.cl. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Chronic hepatitis-B virus (HBV) infection due to mother-to-child transmission (MTCT) during the perinatal period is an important global health concern. Chile is a low-prevalence country with an increasing migratory inflow from Latin- American countries, with intermediate to high endemic rates of HBV infection, and until 2021, there is no universal maternal screening. This study aimed to evaluate infant outcomes using a risk-based strategy of maternal screening to prevent MTCT of hepatitis B virus (HBV) in a low-prevalence country. METHODS: This prospective study included infants born to HBsAg-positive women detected using a local risk-based strategy. The exposed infants received immunoprophylaxis (IP) and follow-up to evaluate their clinical outcomes and immune responses through post-serological vaccine testing (PSVT) after completing the three- dose schedule of the HBV vaccine. RESULTS: A total of 99 HBsAg-positive mothers were detected. Seventy-six (82%) infants completed the follow-up and had PSVT between 9 and 12 months of age. 55.2% female, the median gestational age was 39 weeks (25-41) and the median birth weight was 3,130g (816-4,400 g). All patients received IP with recombinant HBV vaccine plus hepatitis-B virus immunoglobulin (HBIG) and three doses of the HBV vaccine. There were no cases of HBV infection, and 96% (72) responded to immunization with HBsAg antibodies (anti-HBsAg) >10 UI/ml, with a median level of 799 IU/ml. CONCLUSIONS: A high-risk strategy can be implemented in countries with non-universal screening for VHB. Timely IP plus high-uptake VHB vaccination in infants born to HBsAg-positive mothers was associated with a high immunogenic response and absence of MTCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Faculty of Medicine, Universidad de Chile, Santiago, Chile. gizquierdo@uchile.cl.
- Maternity Ward and Neonatal Intensive Care Unit, Complejo Asistencial Barros Luco, Santiago, Chile. gizquierdo@uchile.cl.
- Infectious Diseases Unit, Hospital de niños Dr. Exequiel González Cortés, Santiago, Chile. gizquierdo@uchile.cl.
- Department of Pediatrics, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
- Department of Pediatrics, Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.
- Infectious Diseases Unit, Hospital de niños Dr. Exequiel González Cortés, Santiago, Chile.
Zitieren
APA
Copiz, G. I., Ibañez, C., Piñera, C., Cordova, L., Payá, E., Leal, P., & Villena, R. (2024). Outcome of Infants Born to Women with Chronic Hepatitis B: A Local Risk-Based Strategy in a Low Prevalence Country. Maternal and Child Health Journal. https://doi.org/10.1007/s10995-024-03909-3
Vancouver
Copiz GI, Ibañez C, Piñera C, Cordova L, Payá E, Leal P, et al. Outcome of Infants Born to Women with Chronic Hepatitis B: A Local Risk-Based Strategy in a Low Prevalence Country. Maternal and Child Health Journal. 2024. doi:10.1007/s10995-024-03909-3
BibTeX
@article{Copiz2024,
author = {Copiz, Giannina Izquierdo and Ibañez, Carolina and Piñera, Cecilia and Cordova, Luis and Payá, Ernesto and Leal, Paula and Villena, Rodolfo},
title = {Outcome of Infants Born to Women with Chronic Hepatitis B: A Local Risk-Based Strategy in a Low Prevalence Country},
journal = {Maternal and Child Health Journal},
year = {2024},
doi = {10.1007/s10995-024-03909-3}
}
EUVIMED